🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Glycopyrronium bromide - Medicines in Ireland

22 authorised products containing Glycopyrronium bromide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 22 authorised medicines
MedicineActive substanceLicence holderStatus
Axhidrox 2.2 mg/pump actuation cream
PA0988/003/001
Glycopyrronium bromide Dr. August Wolff GmbH & Co. KG Arzneimittel Marketed
Enerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules
EU/1/20/1438/001-005
Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate Novartis Europharm Limited
Enurev Breezhaler 44 micrograms inhalation powder, hard capsules
EU/1/12/789/001-006
Glycopyrronium bromide Novartis Europharm Limited
Glycopyrronium bromide 200 micrograms/ml Solution for injection
PA0549/029/001
Glycopyrronium bromide Ethypharm Not marketed
Glycopyrronium Bromide 200 micrograms/ml Solution for Injection
PA0857/001/001
Glycopyrronium bromide MercuryPharm Ltd Marketed
Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per ml Solution for Injection
PA0857/002/001
Glycopyrronium bromide, Neostigmine Metilsulfate MercuryPharm Ltd Marketed
Novistig 0.5 mg/ml + 2.5 mg/ml solution for injection
PA22835/003/001
Glycopyrronium bromide, Neostigmine Metilsulfate Sintetica GmbH Not marketed
Riltrava Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension
EU/1/21/1604/001-002
Formoterol fumarate dihydrate, Glycopyrronium bromide, Budesonide AstraZeneca AB
Seebri Breezhaler 44 micrograms inhalation powder, hard capsules
EU/1/12/788/001-006
Glycopyrronium bromide Novartis Europharm Limited
Sialanar 320 micrograms/ml oral solution
EU/1/16/1135/001
Glycopyrronium bromide Proveca Pharma Limited
Tovanor Breezhaler 44 micrograms inhalation powder, hard capsules
EU/1/12/790/001-006
Glycopyrronium bromide Novartis Europharm Limited
Trimbow
EU/1/17/1208/004
Glycopyrronium bromide, Formoterol fumarate dihydrate, Beclometasone dipropionate Chiesi Farmaceutici S.p.A.
Trimbow
EU/1/17/1208/005
Beclometasone dipropionate, Glycopyrronium bromide, Formoterol fumarate dihydrate Chiesi Farmaceutici S.p.A.
Trimbow 172 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution
EU/1/17/1208/006-009
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide Chiesi Farmaceutici S.p.A.
Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution
EU/1/17/1208/001-003
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide Chiesi Farmaceutici S.p.A.
Trimbow 88 micrograms/5 micrograms/9 micrograms inhalation powder
EU/1/17/1208/010-012
Beclometasone dipropionate, Formoterol fumarate dihydrate, GLYCOPYRRONIUM, Glycopyrronium bromide Chiesi Farmaceutici S.p.A.
Trixeo Aerosphere 5/7.2/160 micrograms pressurised inhalation, suspension
EU/1/20/1498/002-003
Budesonide micronised, Glycopyrronium bromide, Formoterol fumarate dihydrate (micronised) AstraZeneca AB
Trydonis 88 micrograms/5 micrograms/9 micrograms inhalation powder
EU/1/18/1274/006-008
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide Chiesi Farmaceutici S.p.A.
Ultibro Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/13/862/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited
Ulunar Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/14/917/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited
Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules
EU/1/13/863/001-006
Indacaterol maleate, Glycopyrronium bromide Novartis Europharm Limited
Zimbus Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules
EU/1/20/1440/001-05
Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate Novartis Europharm Limited
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.